Option Care Health (NASDAQ:OPCH – Get Free Report)‘s stock had its “market perform” rating reaffirmed by investment analysts at Citizens Jmp in a report issued on Wednesday, Benzinga reports.
A number of other brokerages have also commented on OPCH. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $24.00 price target (down from $26.00) on shares of Option Care Health in a research note on Thursday, July 30th. Wall Street Zen upgraded shares of Option Care Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 1st. Barrington Research reissued a “market perform” rating on shares of Option Care Health in a report on Wednesday. Stephens restated an “equal weight” rating and issued a $24.00 price target (down from $30.00) on shares of Option Care Health in a research note on Friday, July 17th. Finally, Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $28.00 to $32.05 in a report on Tuesday. Four equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $29.70.
View Our Latest Stock Analysis on OPCH
Option Care Health Price Performance
Option Care Health (NASDAQ:OPCH – Get Free Report) last issued its earnings results on Wednesday, July 29th. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The business had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same period last year, the business posted $0.41 EPS. The company’s revenue was up 1.9% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, research analysts expect that Option Care Health will post 1.7 EPS for the current fiscal year.
Hedge Funds Weigh In On Option Care Health
Institutional investors and hedge funds have recently bought and sold shares of the stock. Andina Capital Management LLC increased its position in shares of Option Care Health by 2.6% during the 4th quarter. Andina Capital Management LLC now owns 16,320 shares of the company’s stock worth $520,000 after purchasing an additional 419 shares during the last quarter. Pacer Advisors Inc. boosted its stake in Option Care Health by 1.3% during the first quarter. Pacer Advisors Inc. now owns 42,649 shares of the company’s stock worth $1,148,000 after buying an additional 528 shares during the period. Central Pacific Bank Trust Division increased its position in shares of Option Care Health by 3.9% during the third quarter. Central Pacific Bank Trust Division now owns 14,369 shares of the company’s stock valued at $323,000 after acquiring an additional 540 shares during the last quarter. State of Michigan Retirement System increased its position in shares of Option Care Health by 1.6% during the first quarter. State of Michigan Retirement System now owns 38,159 shares of the company’s stock valued at $1,027,000 after acquiring an additional 600 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund raised its stake in shares of Option Care Health by 2.5% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 32,530 shares of the company’s stock valued at $876,000 after acquiring an additional 800 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.
Option Care Health News Roundup
Here are the key news stories impacting Option Care Health this week:
- Positive Sentiment: CD&R and McKesson agreed to acquire Option Care Health for $32.05 per share in cash, valuing the company at approximately $5.8 billion including debt. The offer represents a 37% premium to the prior closing price and provides a clear near-term valuation catalyst. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
- Positive Sentiment: The stock surged on unusually heavy volume following the buyout announcement. A reported spike in call-option activity, with 5,219 calls purchased versus typical daily volume of 281, reflects strong speculative interest surrounding the transaction. Option Care Health Rockets as CD&R, McKesson Table 37% Premium Bid
About Option Care Health
Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.
Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.
Further Reading
- Five stocks we like better than Option Care Health
- RPM International’s Dividend King Status Just Got Stronger
- The AI Boom’s Next Big Winners May Wear Hard Hats
- Rivian Escapes the EV Graveyard—But Can It Stay Alive?
- Allient’s Data Center and Defense Momentum Is Raising the Stakes
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
